<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bowling CB</submitter><funding>NIA NIH HHS</funding><funding>AHRQ HHS</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIAMS NIH HHS</funding><funding>CSRD VA</funding><pagination>1236-43</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4934847</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(7)</volume><pubmed_abstract>&lt;h4>Background and objectives&lt;/h4>Falls are common and associated with adverse outcomes in patients on dialysis. Limited data are available in earlier stages of CKD.&lt;h4>Design, setting, participants, &amp; measurements&lt;/h4>We analyzed data from 8744 Reasons for Geographic and Racial Differences in Stroke Study participants ≥65 years old with Medicare fee for service coverage. Serious fall injuries were defined as a fall-related fracture, brain injury, or joint dislocation using Medicare claims. Hazard ratios (HRs) for serious fall injuries were calculated by eGFR and albumin-to-creatinine ratio (ACR). Among 2590 participants with CKD (eGFR&lt;60 ml/min per 1.73 m(2) or ACR≥30 mg/g), cumulative mortality after a serious fall injury compared with age-matched controls without a fall injury was calculated.&lt;h4>Results&lt;/h4>Overall, 1103 (12.6%) participants had a serious fall injury over 9.9 years of follow-up. The incidence rates per 1000 person-years of serious fall injuries were 21.7 (95% confidence interval [95% CI], 20.3 to 23.2), 26.6 (95% CI, 22.6 to 31.3), and 38.3 (95% CI, 31.2 to 47.0) at eGFR levels ≥60, 45-59, and &lt;45 ml/min per 1.73 m(2), respectively, and 21.3 (95% CI, 20.0 to 22.8), 31.7 (95% CI, 27.5 to 36.5), and 42.2 (95% CI, 31.3 to 56.9) at ACR levels &lt;30, 30-299, and ≥300 mg/g, respectively. Multivariable adjusted HRs for serious fall injuries were 0.91 (95% CI, 0.76 to 1.09) and 1.09 (95% CI, 0.86 to 1.37) for eGFR=45-59 and &lt;45 ml/min per 1.73 m(2), respectively, versus eGFR≥60 ml/min per 1.73 m(2) and 1.31 (95% CI, 1.11 to 1.54) and 1.81 (95% CI, 1.30 to 2.50) for ACR=30-299 and ≥300 mg/g, respectively, versus ACR&lt;30 mg/g. Among participants with CKD, cumulative 1-year mortality rates among patients with a serious fall and age-matched controls were 21.0% and 5.5%, respectively.&lt;h4>Conclusions&lt;/h4>Elevated ACR but not lower eGFR was associated with serious fall injuries. Evaluation for fall risk factors and fall prevention strategies should be considered for older adults with elevated ACR.</pubmed_abstract><journal>Clinical journal of the American Society of Nephrology : CJASN</journal><pubmed_title>Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults.</pubmed_title><pmcid>PMC4934847</pmcid><funding_grant_id>U01 NS041588</funding_grant_id><funding_grant_id>R03 AG042336</funding_grant_id><funding_grant_id>K12 HS023009</funding_grant_id><funding_grant_id>K24 HL125704</funding_grant_id><funding_grant_id>IK2 CX000856</funding_grant_id><funding_grant_id>P50 AR060772</funding_grant_id><pubmed_authors>Muntner P</pubmed_authors><pubmed_authors>Judd SE</pubmed_authors><pubmed_authors>Bowling CB</pubmed_authors><pubmed_authors>Curtis JR</pubmed_authors><pubmed_authors>Shimbo D</pubmed_authors><pubmed_authors>McClellan W</pubmed_authors><pubmed_authors>Reynolds K</pubmed_authors><pubmed_authors>Bromfield SG</pubmed_authors><pubmed_authors>Gutierrez OM</pubmed_authors><pubmed_authors>Wright NC</pubmed_authors><pubmed_authors>Warnock DG</pubmed_authors><pubmed_authors>Colantonio LD</pubmed_authors><pubmed_authors>Franch H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults.</name><description>&lt;h4>Background and objectives&lt;/h4>Falls are common and associated with adverse outcomes in patients on dialysis. Limited data are available in earlier stages of CKD.&lt;h4>Design, setting, participants, &amp; measurements&lt;/h4>We analyzed data from 8744 Reasons for Geographic and Racial Differences in Stroke Study participants ≥65 years old with Medicare fee for service coverage. Serious fall injuries were defined as a fall-related fracture, brain injury, or joint dislocation using Medicare claims. Hazard ratios (HRs) for serious fall injuries were calculated by eGFR and albumin-to-creatinine ratio (ACR). Among 2590 participants with CKD (eGFR&lt;60 ml/min per 1.73 m(2) or ACR≥30 mg/g), cumulative mortality after a serious fall injury compared with age-matched controls without a fall injury was calculated.&lt;h4>Results&lt;/h4>Overall, 1103 (12.6%) participants had a serious fall injury over 9.9 years of follow-up. The incidence rates per 1000 person-years of serious fall injuries were 21.7 (95% confidence interval [95% CI], 20.3 to 23.2), 26.6 (95% CI, 22.6 to 31.3), and 38.3 (95% CI, 31.2 to 47.0) at eGFR levels ≥60, 45-59, and &lt;45 ml/min per 1.73 m(2), respectively, and 21.3 (95% CI, 20.0 to 22.8), 31.7 (95% CI, 27.5 to 36.5), and 42.2 (95% CI, 31.3 to 56.9) at ACR levels &lt;30, 30-299, and ≥300 mg/g, respectively. Multivariable adjusted HRs for serious fall injuries were 0.91 (95% CI, 0.76 to 1.09) and 1.09 (95% CI, 0.86 to 1.37) for eGFR=45-59 and &lt;45 ml/min per 1.73 m(2), respectively, versus eGFR≥60 ml/min per 1.73 m(2) and 1.31 (95% CI, 1.11 to 1.54) and 1.81 (95% CI, 1.30 to 2.50) for ACR=30-299 and ≥300 mg/g, respectively, versus ACR&lt;30 mg/g. Among participants with CKD, cumulative 1-year mortality rates among patients with a serious fall and age-matched controls were 21.0% and 5.5%, respectively.&lt;h4>Conclusions&lt;/h4>Elevated ACR but not lower eGFR was associated with serious fall injuries. Evaluation for fall risk factors and fall prevention strategies should be considered for older adults with elevated ACR.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jul</publication><modification>2025-04-22T02:21:05.503Z</modification><creation>2019-03-27T02:17:41Z</creation></dates><accession>S-EPMC4934847</accession><cross_references><pubmed>27091516</pubmed><doi>10.2215/cjn.11111015</doi><doi>10.2215/CJN.11111015</doi></cross_references></HashMap>